InforSense and GeneGo are integrating their technologies to allow researchers to better probe their data and share their work process across different research domains
InforSense has joined forces with GeneGo, a leading provider of systems biology tools and databases.
The companies are integrating their technologies to allow researchers to better probe their data and share their work process across different research domains.
GeneGo has also joined the InforSense Open Workflow Partner Network.
The integration of GeneGo's unique reference system for curated pathway analysis and InforSense's integrated, interactive workflow-based data mining technology allows researchers to query their data and share their results across the research and development value chain.
In addition to the integration of InforSense KDE and MetaCore, which is already available, the companies are in the process of integrating InforSense KDE with both MetaDrug and MetaBase.
Customer feedback supports integration of GeneGo's software suite with the proven InforSense workflow technology, as researchers will be enabled to bridge domains such as genomics and metabolomics with high confidence data using a systems biology approach.
In addition, users will be able to annotate pathway data with experimental results and clinical data and thereby better predict patient outcomes.
"The collaboration between InforSense and GeneGo will deliver to thousands of users the needed environment for leveraging high-throughput biology and chemistry data more effectively for better and faster decision-making within the life science industry," said Julie Bryant, vice president of business development of GeneGo.
"InforSense workflows enable life science researchers to compose and execute scientific analyses quickly and easily without programming, sharing both methods and results with co-workers." "MetaCore has grown to become a key component in the research toolbox in the life sciences, particularly within the pharmaceutical industry, and we are pleased to have the opportunity to work with GeneGo," commented Jonathan Sheldon, chief scientific officer, InforSense.
"The integration of pathway analysis with InforSense KDE is a key component of our multidisciplinary analytics platform for Systems Biology." GeneGo develops tools for integration and systems level analysis of high-throughput experimental data in human biology and medicinal chemistry.
The flagship product, MetaCore, is designed to assist scientists in drug target selection, validation, and identification of molecular biomarkers for disease states.
MetaCore is an integrated analytical suite with intuitive interface, data parsers and visualization tools and flexible network building algorithms working on the proprietary content of MetaBase - its manually curated database on human biology in norm and diseases.
The most comprehensive database in the field, MetaBase allows one to network over 90% of the known human proteins via physical protein-protein, protein-DNA and protein-compound interactions.
GeneGo's second product, MetaDrug, deals with prediction of human metabolism and toxicity of novel small molecules and compounds.
Customers include many of the largest pharmaceutical companies and leading university labs.
GeneGo was founded in 2000 by Tatiana Nikolskaya, then a wet lab molecular biologist at the University of Chicago.
GeneGo has business offices in San Diego, CA, Munich, Germany and a research facility in Moscow, Russia.
